David Scott Miller


AuthID: R-00K-250

Confirmed Publications: 294



11
TITLE: Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice  Full Text
AUTHORS: Domenica Lorusso; Nicoletta Colombo; Antonio Casado Herraez; Alessandro D Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally E Baron Hay; Isabelle Laure Ray Coquard; Ronnie Shapira Frommer; Yong Man Kim; Mary McCormack; Rachid Massaad; Allison Martin Nguyen; Qi Zhao; Jodi McKenzie; Vimalanand S Prabhu; Vicky Makker;
PUBLISHED: 2023, SOURCE: European Journal of Cancer, VOLUME: 186
INDEXED IN: Scopus CrossRef: 2
IN MY: ORCID | CIÊNCIAVITAE
12
TITLE: Isolated para-aortic nodal recurrence after treatment of early stage cervical carcinoma
AUTHORS: Steven B Holloway; Alyssa J Mercadel; David Scott Miller ; Jayanthi S Lea;
PUBLISHED: 2023, SOURCE: Gynecologic Oncology, VOLUME: 170
INDEXED IN: Scopus CrossRef
IN MY: ORCID | CIÊNCIAVITAE
13
TITLE: Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley J Monk; Helen MacKay; Alessandro D Santin; David Scott Miller ; Richard G Moore; Sally Baron Hay; Isabelle Ray Coquard; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Steven Bird; Robert Orlowski; Jodi McKenzie; Chinyere Okpara; Gianmaria Barresi; Domenica Lorusso; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 16
INDEXED IN: Scopus CrossRef: 16
IN MY: ORCID | CIÊNCIAVITAE
14
TITLE: Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
AUTHORS: Ignace Vergote; Jose Alejandro Pérez-Fidalgo; Erika Paige Hamilton; Giorgio Valabrega; Toon Van Gorp; Jalid Sehouli; David Cibula; Tally Levy; Stephen Welch; Debra L Richardson; Eva M Guerra; Giovanni Scambia; Stéphanie Henry; Pauline Wimberger; David Scott Miller ; Jaroslav Klat; Jerónimo Martínez-Garcia; Francesco Raspagliesi; Bhavana Pothuri; Ignacio Romero; Alice Bergamini; Brian Slomovitz; Fabienne Schochter; Estrid Høgdall; Lorena Fariñas-Madrid; Bradley J Monk; Dayana Michel; Michael G Kauffman; Sharon Shacham; Mansoor Raza Mirza; Vicky Makker; Ignace Vergote; Toon Van Gorp; Isabelle Cadron; Annelore Barbeaux; Nathalie Cornez; Stephanie Henry; Joseph Kerger; Debbie Debaere; Hannelore Denys; Mansoor Raza Mirza; Amit Oza; Lucy Gilbert; Stephen Welch; Michael Kolinsky; Qi Zhou; Jing Wang; Yingjie Yang; Kaijia Tu; Li Wang; Danbo Wang; Ge Lou; Xiaojian Yan; Jiaxin Yang; David Cibula; Jaroslav Klat; Bohuslav Melichar; Michal Zikan; Klaudia Reginacova; Vit Weinberger; Jalid Sehouli; Pauline Wimberger; Dirk Bauerschlag; Fabian Trillsch; Oliver Tome; Fabienne Schochter; Marco Battista; Bahriye Aktas; Kristina Luebbe; Mustafa Deryal; George Fountzilas; Athina Christopoulou; Christos Papadimitriou; Flora Zagouri; Limor Helpman; Tamar Safra; Tally Levy; Ilan Bruchim; Ora Rosengarten; Aviad Zick; Giorgio Valabrega; Giovanni Scambia; Giorgia Mangili; Francesco Raspagliesi; Carmela Pisano; Donata Sartori; Ugo de Giorgi; Jose Alejandro Perez-Fidalgo; Cesar Gomez-Raposo; Ignacio Romero; Maria Iglesias; Ana Santaballa; Nerea Ancizar; Purificación Estévez; Constanza Maximiano; Alfonso Yubero; Ana Oaknin; Eva Guerra; Lydia Gaba; Jeronimo Martinez; Emma Dotor; Vicky Makker; Debra Richardson; Jonathan Berek; Hye Sook Chon; Joseph Buscema; Meaghan Tenney; David Miller; Gregory Sutton; Daniel Spitz; Kristopher LyBarger; Erika Hamilton; Gregory Gilmore; Merrill Shum; Harshad Amin; Leslie Randall; Bhavana Pothuri; Katina Robison; Jonathan Boone; Joyce Barlin; Sharad Ghamande; Alfred Guirguis; Sudarshan Sharma; Iwona Podzielinski; Lisa Landrum; Nicole Nevadunsky; Amanda Jackson; Eirwen Miller; Radhika Gogoi; Bradley Monk; Restituto Tibayan; Noelle Cloven; Joseph de la Garza; Christine Lee; Carolyn Mathews; Anna Priebe; Michael Teneriello; Charles Anderson; Bhavana Pothuri; Fabio Cappuccini; David Miller; Michael G Kaufman; Sharon Shacham; Yosef Landesman; Christopher J Walker; Xulong Wang; Feng Wang; Changting Meng; Dayana Michel; Patricia Judson; Reshma Rangwala; ...More
PUBLISHED: 2023, SOURCE: Journal of Clinical Oncology, VOLUME: 41, ISSUE: 35
INDEXED IN: Scopus CrossRef: 5
IN MY: ORCID
15
TITLE: Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
AUTHORS: Christopher A Walker; Alexandra N Spirtos; David Scott Miller ;
PUBLISHED: 2023, SOURCE: Expert Review of Anticancer Therapy, VOLUME: 23, ISSUE: 4
INDEXED IN: Scopus CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
16
17
TITLE: 17 Pre-operative patient characteristics predict outpatient opioid use
AUTHORS: Alexandra Spirtos; Bethany Werner; Jackson Barth; Thomas Parnell; Austin Street; Salvatore LoCoco; Matthew Carlson; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology Reports, VOLUME: 44
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
18
TITLE: 18 Obesity as a post-operative risk factor for women undergoing open radical hysterectomy
AUTHORS: Bethany Werner; Steven B Holloway; Kevin M Kremer; Salvatore LoCoco; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology Reports, VOLUME: 44
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
19
TITLE: 2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775
AUTHORS: Domenica Lorusso; Vicky Makker; Antonio Casado Herraez; Bradley J Monk; Helen Mackay; Alessandro D Santin; David Scott Miller ; Richard Moore; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva M Guerra Alia; Ulus A Sanli; Jie Huang; Jodi McKenzie; Gianmaria Barresi; Nicoletta Colombo;
PUBLISHED: 2022, SOURCE: Endometrial cancer
INDEXED IN: CrossRef: 2
IN MY: ORCID | CIÊNCIAVITAE
20
TITLE: 2022-RA-722-ESGO Phase 2 study assessing the efficacy of adding AL3818 (Catequentinib Dihydrochloride, Anlotinib Hydrochloride) to chemotherapies in subjects with platinum resistant ovarian carcinoma  Full Text
AUTHORS: David Scott Miller ; Matthew Carlson; Jayanthi Lea; Zhe Li; May Gan; Judy Chen; Agustin Garcia; Matthew Schlumbrecht; Matt Pearson; Marilyn Huang;
PUBLISHED: 2022, SOURCE: Ovarian cancer
INDEXED IN: CrossRef
IN MY: ORCID | CIÊNCIAVITAE
Page 2 of 30. Total results: 294.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service